154 related articles for article (PubMed ID: 27643557)
21. Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy.
Scharf MM; Bünemann M; Baker JG; Kolb P
Mol Pharmacol; 2019 Dec; 96(6):851-861. PubMed ID: 31624135
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel serotonin 2C receptor ligands by sequential virtual screening.
Ahmed A; Choo H; Cho YS; Park WK; Pae AN
Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901
[TBL] [Abstract][Full Text] [Related]
23. Combination of Pharmacophore Matching, 2D Similarity Search, and In Vitro Biological Assays in the Selection of Potential 5-HT6 Antagonists from Large Commercial Repositories.
Dobi K; Flachner B; Pukáncsik M; Máthé E; Bognár M; Szaszkó M; Magyar C; Hajdú I; Lőrincz Z; Simon I; Fülöp F; Cseh S; Dormán G
Chem Biol Drug Des; 2015 Oct; 86(4):864-80. PubMed ID: 25823681
[TBL] [Abstract][Full Text] [Related]
24. N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand.
Kaczor AA; Targowska-Duda KM; Stępnicki P; Silva AG; Koszła O; Kędzierska E; Grudzińska A; Kruk-Słomka M; Biała G; Castro M
Neurochem Int; 2021 Jun; 146():105016. PubMed ID: 33722679
[TBL] [Abstract][Full Text] [Related]
25. Constructing an atomic-resolution model of human P2X7 receptor followed by pharmacophore modeling to identify potential inhibitors.
Ahmadi M; Nowroozi A; Shahlaei M
J Mol Graph Model; 2015 Sep; 61():243-61. PubMed ID: 26298810
[TBL] [Abstract][Full Text] [Related]
26. Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13).
Sousbie M; Vivancos M; Brouillette RL; Besserer-Offroy É; Longpré JM; Leduc R; Sarret P; Marsault É
J Med Chem; 2018 Aug; 61(16):7103-7115. PubMed ID: 30035538
[TBL] [Abstract][Full Text] [Related]
27. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
28. Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators.
Pinkerton AB; Peddibhotla S; Yamamoto F; Slosky LM; Bai Y; Maloney P; Hershberger P; Hedrick MP; Falter B; Ardecky RJ; Smith LH; Chung TDY; Jackson MR; Caron MG; Barak LS
J Med Chem; 2019 Sep; 62(17):8357-8363. PubMed ID: 31390201
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
[TBL] [Abstract][Full Text] [Related]
30. Optimized method of G-protein-coupled receptor homology modeling: its application to the discovery of novel CXCR7 ligands.
Yoshikawa Y; Oishi S; Kubo T; Tanahara N; Fujii N; Furuya T
J Med Chem; 2013 Jun; 56(11):4236-51. PubMed ID: 23656360
[TBL] [Abstract][Full Text] [Related]
31. In-silico guided discovery of novel CCR9 antagonists.
Zhang X; Cross JB; Romero J; Heifetz A; Humphries E; Hall K; Wu Y; Stucka S; Zhang J; Chandonnet H; Lippa B; Ryan MD; Baber JC
J Comput Aided Mol Des; 2018 Apr; 32(4):573-582. PubMed ID: 29582229
[TBL] [Abstract][Full Text] [Related]
32. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
[TBL] [Abstract][Full Text] [Related]
33. Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy.
Orwig KS; Lassetter MR; Hadden MK; Dix TA
J Med Chem; 2009 Apr; 52(7):1803-13. PubMed ID: 19290594
[TBL] [Abstract][Full Text] [Related]
34. Allosteric modulation of endogenous metabolites as an avenue for drug discovery.
Wootten D; Savage EE; Valant C; May LT; Sloop KW; Ficorilli J; Showalter AD; Willard FS; Christopoulos A; Sexton PM
Mol Pharmacol; 2012 Aug; 82(2):281-90. PubMed ID: 22576254
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ
J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821
[TBL] [Abstract][Full Text] [Related]
36. Peptide backbone modifications on the C-terminal hexapeptide of neurotensin.
Einsiedel J; Hübner H; Hervet M; Härterich S; Koschatzky S; Gmeiner P
Bioorg Med Chem Lett; 2008 Mar; 18(6):2013-8. PubMed ID: 18276136
[TBL] [Abstract][Full Text] [Related]
37. A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.
Sanders MP; Roumen L; van der Horst E; Lane JR; Vischer HF; van Offenbeek J; de Vries H; Verhoeven S; Chow KY; Verkaar F; Beukers MW; McGuire R; Leurs R; Ijzerman AP; de Vlieg J; de Esch IJ; Zaman GJ; Klomp JP; Bender A; de Graaf C
J Med Chem; 2012 Jun; 55(11):5311-25. PubMed ID: 22563707
[TBL] [Abstract][Full Text] [Related]
38. Identification of a pyrogallol derivative as a potent and selective human TLR2 antagonist by structure-based virtual screening.
Grabowski M; Murgueitio MS; Bermudez M; Rademann J; Wolber G; Weindl G
Biochem Pharmacol; 2018 Aug; 154():148-160. PubMed ID: 29684378
[TBL] [Abstract][Full Text] [Related]
39. Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands.
Rosano C; Ponassi M; Santolla MF; Pisano A; Felli L; Vivacqua A; Maggiolini M; Lappano R
AAPS J; 2016 Jan; 18(1):41-6. PubMed ID: 26573009
[TBL] [Abstract][Full Text] [Related]
40. Identification of potential dual agonists of FXR and TGR5 using e-pharmacophore based virtual screening.
Sindhu T; Srinivasan P
Mol Biosyst; 2015 May; 11(5):1305-18. PubMed ID: 25787676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
